Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03700645
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03700645
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03700645. Randomized; no masking; primary purpose prevention. Start 2018-12-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
- Condition
- Diabetes Mellitus
- Condition
- Ischemic Heart Disease
- Condition
- Multi Vessel Coronary Artery Disease
- Intervention (Drug)
- Allopurinol
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
Record details
- Record id
cardio:ct-nct03700645- Content hash
c0da34ab00c27940562298aa5919b4cabe05861254e24750ebb0e92015618417